These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20386054)

  • 41. Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
    Quintal C; Antunes M
    Acta Med Port; 2023 Sep; 36(9):577-587. PubMed ID: 37339163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Access to Personal Health Records and Screening for Breast and Cervical Cancer Among Women with a Family History of Cancer.
    Kim H; Mahmood A; Carlton E; Goldsmith J; Chang C; Bhuyan S
    J Cancer Educ; 2020 Dec; 35(6):1128-1134. PubMed ID: 31264113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 44. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
    Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
    Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
    Harper DM; Plegue M; Jimbo M; Sheinfeld Gorin S; Sen A
    Elife; 2022 Jun; 11():. PubMed ID: 35762572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization.
    Dietrich AJ; Tobin JN; Cassells A; Robinson CM; Reh M; Romero KA; Flood AB; Beach ML
    Ann Fam Med; 2007; 5(4):320-7. PubMed ID: 17664498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health-care providers' perceptions, attitudes towards and recommendation practice of cervical cancer screening.
    Hweissa NA; Lim JN; Su TT
    Eur J Cancer Care (Engl); 2016 Sep; 25(5):864-70. PubMed ID: 27350095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
    Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
    Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
    MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
    J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies for expanding colorectal cancer screening at community health centers.
    Sarfaty M; Doroshenk M; Hotz J; Brooks D; Hayashi S; Davis TC; Joseph D; Stevens D; Weaver DL; Potter MB; Wender R
    CA Cancer J Clin; 2013; 63(4):221-31. PubMed ID: 23818334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer screening of older women : a primary care issue.
    Blair KA
    Cancer Pract; 1998; 6(4):217-22. PubMed ID: 9767334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contextual factors associated with uptake of breast and cervical cancer screening: A systematic review of the literature.
    Plourde N; Brown HK; Vigod S; Cobigo V
    Women Health; 2016; 56(8):906-25. PubMed ID: 26812962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer screening estimates for U.S. metropolitan areas.
    Nelson DE; Bolen J; Marcus S; Wells HE; Meissner H
    Am J Prev Med; 2003 May; 24(4):301-9. PubMed ID: 12726867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report.
    Puleo E; Zapka JG; Goins KV; Yood MU; Mouchawar J; Manos M; Somkin C; Taplin S
    Eval Health Prof; 2005 Sep; 28(3):310-27. PubMed ID: 16123260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention.
    Eur J Cancer; 2000 Aug; 36(12):1473-8. PubMed ID: 10930794
    [No Abstract]   [Full Text] [Related]  

  • 59. What is the most cost-effective population-based cancer screening program for Chinese women?
    Woo PP; Kim JJ; Leung GM
    J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening.
    Yabroff KR; Kerner JF; Mandelblatt JS
    Prev Med; 2000 Oct; 31(4):429-39. PubMed ID: 11006069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.